The assisted reproductive technologies (ART) market size is projected to reach USD 45.06 billion by 2026, exhibiting a CAGR of 9.8% during the forecast period. The market was valued at USD 21.32 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Assisted Reproductive Technologies (ART) Market Size, Share & Industry Analysis, By Technique (In-Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Transfer (FET), and Others), By Procedure (Fresh Donor, Fresh Non-donor, Frozen Donor, and Frozen Non-donor), By End User (Fertility Clinics, and Hospitals) and Regional Forecast, 2019-2026.” As per the report, increasing stress levels amongst the population is likely to result in the rising prevalence of infertility. It will aid in the fertility services market growth during the forecast period.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/assisted-reproductive-technologies-market-101147
Fresh Non-donor Segment to Lead Backed by High Success Rate of Procedures
By procedure, the assisted reproductive technologies (ART) market is divided into fresh donor, frozen donor, fresh non-donor, and frozen non-donor. Amongst these, the fresh non-donor segment is expected to acquire a high CAGR in the coming years owing to the high success rate of procedures by utilizing fresh embryos or eggs. Also, the rising incidence of infertility is expected to boost the growth of this segment. The Oxford Journals, for instance, had published a study that was conducted in 2017. It states that around 19.0% of all fertility cycles would cause live birth if the used egg is not frozen. The frozen non-donor segment, on the other hand, currently holds the second position owing to its cost-effective nature as compared to those cycles that use fresh embryos or eggs. The rest of the segments would also exhibit a healthy CAGR in the coming years.
Europe to Dominate: Increasing Prevalence of Fertility to Favor Growth
The assisted reproductive technologies market is geographically segregated into North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Out of these, Europe had acquired USD 8.78 billion ART market revenue in 2018. It is expected to retain its dominance throughout the forthcoming years. This growth is attributable to the rising incidence of infertility that is further leading to increasing demand for ART procedures.
Reasons to Purchase this Report
- Comprehensive analysis of the global ART market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
The Assisted Reproductive Technologies (ART) market size is projected to reach USD 45.06 billion by 2026, exhibiting a CAGR of 9.8% during the forecast period.
The market was valued at USD 21.32 billion in 2018.
This information is published in a recent report by Fortune Business Insights, titled, “Assisted Reproductive Technologies (ART) Market Size, Share & Industry Analysis, By Technique (In-Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Transfer (FET), and Others), By Procedure (Fresh Donor, Fresh Non-donor, Frozen Donor, and Frozen Non-donor), By End User (Fertility Clinics, and Hospitals) and Regional Forecast, 2019-2026.” As per the report, increasing stress levels amongst the population is likely to result in the rising prevalence of infertility.
The National Survey of Family Growth (NSFG) stated that around 6.7% of women residing in the U.S. were affected by infertility in 2018.
The age group was between 15 to 44 years.
Moreover, it is not only the women who are suffering from infertility nowadays.The Oxford Journals published a study that mentioned that in the U.K., one out of ten men from the age group of 16 to 74 years is affected by infertility.
Emergen Research’s latest document, titled ‘Global Assistive Reproductive Technology Market - Forecast to 2027,’ is one of the most sought-after market reports involving an in-depth analysis of the global Assistive Reproductive Technology market.
The report’s authors have offered necessary details on the latest Assistive Reproductive Technology market trends and the crucial parameters impacting both short-term and long-term market growth.
Its panoramic view of the Assistive Reproductive Technology industry entails useful insights into the estimated Assistive Reproductive Technology market size, revenue share, and sales & distribution networks.The global assisted reproductive technology market size was valued at USD 24.62 Billion in 2019 and is forecasted to reach USD 50.32 Billion by 2027 at a CAGR of 9.3%.
The market for assisted reproductive technology (ART) is experiencing rapid growth attributed to the surging popularity of in-vitro fertilization (IVF) (with or without Intracytoplasmic Sperm Injection (ICSI)) and artificial insemination-intrauterine (AI-IUI), among other technologies.Market Drivers:The constant efforts of prominent players to develop newer and modern technologies and product advancements are expected to drive the growth of the industry over the coming years.
The report studies the extensive business expansion plans and advancements in R activities and product portfolio.
The report offers a clear understanding of the alliances in the market, such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches and brand promotions, and corporate deals.To get a sample copy of the Global Assistive Reproductive Technology Market report, visit @https://www.emergenresearch.com/request-sample/165 Segmental Analysis· Procedure Outlook (Revenue, USD Billion; 2017-2027)Fresh DonorFresh Non-DonorFrozen DonorFrozen Non-DonorEgg/Embryo Banking· Technology Outlook (Revenue, USD Billion; 2017-2027)In-Vitro Fertilization (IVF)In-Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)In-Vitro Fertilization (IVF) without Intracytoplasmic Sperm Injection (ICSI)Artificial Insemination-Intrauterine (AI-IUI)Regional Analysis of the Assistive Reproductive Technology Market:North America (U.S., Canada)Europe (U.K., Italy, Germany, France, Rest of EU)Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)Latin America (Chile, Brazil, Argentina, Rest of Latin America)Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)To learn more details about the Global Assistive Reproductive Technology Market report, visit @https://www.emergenresearch.com/industry-report/assistive-reproductive-technology-market Thank you for reading our report.
This report studies the global market size of Atovaquone in key regions like North America, Europe,Asia Pacific, Central & South America and Middle East & Africa, focuseson the consumption of Atovaquone inthese regions.
This report also studies the global market status, competitionlandscape, market share, growth rate, future trends, market drivers,opportunities and challenges, sales channels, distributors and Porter’s FiveForces Analysis.
Market size split by Region
Rest of Central & South America
The study objectives of this report are:
To study and analyze the global Atovaquone market size (value & volume) by company,key regions/countries, products and application, history data from 2013 to2017, and forecast to 2025.
Barley - MARKET ADVISORY SERVICES
Barley report studies the global market size of it in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Barley in these regions.The increasing demand for food and beverage package drives the growth of market.
The global Barley market is shifting rapidly.
EMEA accounted for the maximum shares of the barley grain market during 2017.APAC market is expected to grow due rapid population growth and cheap human labor.
The launch of packaged food and beverage containing barley ingredients as one of the primary factors that will trigger the growth of the barley market in the coming years.
The manufacturers of the packaged food and beverage market focus on offering products containing barley as an ingredient to attract health-aware customers.
Diabetes can be described as a disease, which is marked by high levels of blood glucose resulting from defects in insulin production and insulin action. The disease has become a global epidemic leading to serious complications and ultimately resulting in premature death. Diabetes affects several organs of the body including eyes, kidneys, heart. However, it has been observed that the feet in particular are affected due to damage done to the nerves without immediate/early detection. People suffering from diabetes suffer from feet ulceration that results are usually associated with high treatment expenses.
The global diabetic shoes market is expected to witness a steady growth during the forecast period due to the increasing incidence of diabetes globally. Rising skin related problems in the feet due to diabetes is another reason that is triggering the demand for diabetic shoes. The physicians prescribe diabetic footwear to the patients suffering from diabetes in order to prevent all feet related complications. Owing to high level of comfort and convenience of wearing the diabetic shoes, the global market is expected to grow steadily throughout the forecast period.
Get Sample Copy Of The Report@ https://www.trendsmarketresearch.com/report/sample/3678
In order to get a better understanding of the global diabetic shoes market, a key trends analysis has been included for all the segments. In addition, the market players in the diabetic shoes market have also been profiled. The leading players in the market include. Aetrex Worldwide, Inc. (New Jersey, US State), PodartisSrl. (Montebelluna, Italy), Etonic Worldwide LLC (New York, U.S), Dr. Comfort, LLC. (Wisconsin, U.S.), Advance Diabetic Solution (Georgia, U.S.A), Apex Foot Health Industries LLC ( New York, U.S.A), Dr Zen Products, Inc. (Florida, U.S.A.), DARCO International, Inc (West Virginia, U.S.A), Orthofeet Inc.( New Jersey, U.S.A.) and Drew Shoe Corporation. (Ohio, U.S.A ) among others.
Later on, it was seen that foot has become a complex biomechanical and anatomical structure. Therefore, a complete study of the feet was essential in order to make a diabetic shoe in order to prevent the foot injury. Therapeutic or diabetic shoes are specifically designed to reduce the problems in the feet of the person suffering from diabetes. Diabetes create changes in the skin of the foot due to the damaged nerves, which are no longer functional and prevents moisture and oil secretions. Increasing awareness about the presence of diabetic shoes in the market and the increasing need to lead a healthy lifestyle is one of the key factors propelling the growth of the diabetic shoes market across the globe.
Global Diabetic Shoes market can be segmented as follows;-
§ Global Diabetic shoes Market, by Distribution Channel
• Online Stores
• Specialty Stores
• Shoes Stores
• Departmental Stores
• Super Market & Hyper Market
§ Global Diabetic Shoes Market, by End Use
• Women
• Men
§ Global Diabetic Shoes Market, by Geography
• North America
• U.S.
• Rest of North America
• Europe
• U.K.
• Germany
• France
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of APAC
• Middle East
• U.A.E.
• Saudi Arabia
• Qatar
• Kuwait
• Oman
• Rest of Middle East
• Africa
• South Africa
• Rest of Africa
• Latin America
• Brazil
• Rest of Latin America
Report For Sample with TOC@ https://www.trendsmarketresearch.com/report/requesttoc/3678
Diabetic footwear is prescribed by physicians to reduce the complications of a person suffering from diabetes. The consumers must be aware that the diabetic shoe matches the size of the foot and also the shoe has enough room for the toes at the sides and front as well as the top so that the pressure of the shoe are not felt. People with diabetes are highly prone to disrupted blood circulation to the foot resulting due to nerve damage. Disrupted blood circulation results to loss of sensation in the foot, thus causing wounds or ulcers that take a fair amount of time to heal. However, lack of awareness among the consumers regarding the benefits of diabetic shoes is restraining the global diabetic shoes market. Moreover, increasing brand presence and roles of e-commerce are generating opportunities to the diabetic shoes market in recent years and this growth is expected to boost the global diabetic shoes market during the forecast period.
However, diabetic shoes, although act as a convenience for the patients suffering from diabetes, they however, does not help reduce the same. Diabetic shoes are used to comfort the consumers inducing proper blood circulation compared to a patient wearing a regular shoe. Consumers largely resort to the consumption of medicines for treating diabetes and various other alternatives, which is why a large portion of the diabetic population refrain themselves from purchasing diabetic shoes, which in turn is a major factor hindering the growth of the diabetic shoes market at present. Moreover, the price of diabetic shoes are on the higher end which another reason that is refraining the consumers falling in the low and middle income category from purchasing diabetic shoes. This is another reason for the consumers to stick to medicinal treatment and related treatments instead of diabetic shoes. However, with rising awareness, the impact of this restraint is expected reduce during the forecast period.
Moreover, in this report the study provides different countries included in different regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America includes the U.S. and Rest of North America. U.K., Germany, Russia, Italy, France and Rest of Europe included in Europe. China, India, Japan and Rest of Asia Pacific included in Asia Pacific diabetic shoes market. In addition, Middle East includes country such as UAE, Saudi Arabia, Qatar, Kuwait, Oman and Rest of Middle East. Africa includes South Africa and Rest of Africa. Latin America comprise of countries such as Brazil and Rest of Latin America.
Report Analysis@ https://www.trendsmarketresearch.com/report/diabetic-shoes-market
One Vincent Square
Westminster, London SW1P 2PN
United Kingdom Phone: +442033221521
Email: [email protected]
Website: https://www.trendsmarketresearch.com
Global Government Cloud Market is expected to reach USD 34.9 Billion by 2024 from USD 14.05 Billion in 2016 at a CAGR of 13.9%.
This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors.
North America is anticipated to experience the highest market growth over the forecast period, this is majorly due to the improved ICT spending in government infrastructure and government cloud initiatives.
The rapid growth in adoption of IAM and the technological advancements taking place in open data platforms are creating opportunities across a wide range of industries and Deployment Models:
• Complete analysis with respect to individual growth trends are incorporated within the scope of our study.
• Assessment of market definition along with the identification of key drivers, restraints opportunities for this market
